|

Mitoxantrone liposome Clinical Trials

1 actively recruiting trial

Also known as: Mitoxantrone Hydrochloride Liposome Injection

Pipeline

Phase 1/2: 1

Top Sponsors

  • Hui Zeng1

Indications

  • Relapsed or Refractory Acute Myeloid Leukemia1
  • Cancer1

Other1 trial

Clinical Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid Leukemia
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.